GI
KRYS icon

GAMMA Investing’s Krystal Biotech KRYS Stock Holding History

GAMMA Investing’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$366K Buy
1,100
+102
+10% +$35.3K 0.01% 893
2026
Q2 		$371K Buy
998
+140
+16% +$41.8K 0.01% 822
2026
Q1 		$222K Buy
858
+69
+9% +$18.4K 0.01% 1039
2025
Q4 		$195K Buy
789
+292
+59% +$61.5K 0.01% 1068
2025
Q3 		$87.7K Buy
497
+212
+74% +$31.7K ﹤0.01% 1593
2025
Q2 		$39.2K Sell
285
-388
-58% -$57K ﹤0.01% 2074
2025
Q1 		$121K Buy
673
+432
+179% +$72.7K 0.01% 1099
2024
Q4 		$37.8K Sell
241
-189
-44% -$33.5K ﹤0.01% 1874
2024
Q3 		$78.3K Buy
430
+279
+185% +$53.8K 0.01% 1169
2024
Q2 		$27.7K Buy
151
+93
+160% +$15.6K ﹤0.01% 1642
2024
Q1 		$10.3K Buy
58
+16
+38% +$2.22K ﹤0.01% 2054
2023
Q4 		$4.67K Buy
+42
New +$4.66K ﹤0.01% 2268

Other funds holding KRYS

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return

GAMMA Investing's KRYS Position: Q3 2026 in Review

GAMMA Investing increased its Krystal Biotech (KRYS) stake by 10% in Q3 2026, buying an estimated $35.3K and bringing the position to 1,100 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #893.

GAMMA Investing first reported a position in KRYS in Q4 2023 and has held it in 12 quarters since. The position peaked at $371K in Q2 2026. 11 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • GAMMA Investing held 1,100 shares of Krystal Biotech worth $366K as of Q3 2026.
  • GAMMA Investing bought 102 Krystal Biotech shares in Q3 2026, an estimated $35.3K.
  • Krystal Biotech made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #893 holding.
  • GAMMA Investing first reported a position in Krystal Biotech in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Krystal Biotech position peaked at $371K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.